Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A double-blind placebo-controlled Phase IIb trial evaluating evaluate the safety and tolerability of RJx-01 in COPD-related sarcopenia

Next Previous
X
Search
Trial Profile

A double-blind placebo-controlled Phase IIb trial evaluating evaluate the safety and tolerability of RJx-01 in COPD-related sarcopenia

Status: Planning
Phase of Trial: Phase II

Latest Information Update: 01 Nov 2024

Price :

$35 *

Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Galantamine/metformin (Primary)
  • Indications Sarcopenia
  • Focus Therapeutic Use

    • Most Recent Events

    • 28 Oct 2024 According to a Rejuvenate Biomed media release, Rejuvenate Biomed, this study will be led by Dr Neil Greening and Dr Hamish McCauley from the NIHR Leicester BRC at University Hospitals of Leicester NHS Trust.
    • 28 Oct 2024 According to a Rejuvenate Biomed media release, Rejuvenate Biomed, the clinical study is enabled by a multimillion dollar award from Wellcome Leap's Dynamic Resilience program (co-funded by Temasek Trust).
    • 28 Oct 2024 According to a Rejuvenate Biomed media release, Rejuvenate Biomed, the University of Leicester, the National Institute for Health and Care Research (NIHR) Leicester Biomedical Research Centre (BRC), and Wellcome Leap Inc. have entered into an agreement to execute a Phase 2 clinical trial in patients with chronic obstructive pulmonary disease (COPD)-related sarcopenia. The company anticipates starting patient enrollment first half 2025.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top